A Non-Interventional Study of the Treatment With Etanercept in Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) Subjects in Rheumatology Department.

Trial Profile

A Non-Interventional Study of the Treatment With Etanercept in Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS) Subjects in Rheumatology Department.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 02 May 2014

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis; Rheumatoid arthritis
  • Focus Adverse reactions
  • Acronyms ENBREL NIS CN
  • Sponsors Pfizer
  • Most Recent Events

    • 05 Mar 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 16 Jan 2013 Planned End Date changed from 1 Nov 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov.
    • 11 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top